Eventide Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
Eventide Asset Management, LLC
- $5.42 Billion
- Q3 2025
A detailed history of Eventide Asset Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 2,522,563 shares of MIRM stock, worth $180 Million. This represents 3.41% of its overall portfolio holdings.
Number of Shares
2,522,563
Previous 2,637,485
4.36%
Holding current value
$180 Million
Previous $134 Million
37.78%
% of portfolio
3.41%
Previous 2.55%
Shares
14 transactions
Others Institutions Holding MIRM
# of Institutions
291Shares Held
57.5MCall Options Held
86.1KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$485 Million21.07% of portfolio
-
Janus Henderson Group PLC London, X05MShares$357 Million0.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$231 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$182 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA1.5MShares$107 Million5.93% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.63B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...